Retrospective study of idiosyncratic drug-induced liver injury from infliximab in an inflammatory bowel disease cohort: the IDLE study

BACKGROUND: Infliximab therapy may be associated with drug-induced liver injury (DILI), often resembling a drug-induced autoimmune hepatitis. However, the prevalence of DILI in patients receiving infliximab is unclear. Abnormal liver biochemistry is common in patients with inflammatory bowel disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Worland, Thomas, Chin, Ken Lee, van Langenberg, Daniel, Garg, Mayur, Nicoll, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049241/
https://www.ncbi.nlm.nih.gov/pubmed/32127737
http://dx.doi.org/10.20524/aog.2020.0453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049241/
https://www.ncbi.nlm.nih.gov/pubmed/32127737
http://dx.doi.org/10.20524/aog.2020.0453

Ejemplares similares